Once stable at a therapeutic dose, additional compounds can be reintroduced one at a time
Arg methylase inhibitors (AMIs), symmetric sulfonated urea, specifically inhibit PRMT activity and, in a rat model, cyclooxygenase-2 (COX-2) expression and suppress inflammation
Future introduction of individual supplementation algorithms based on baseline micronutrient levels, underlying or at-risk clinical conditions, and perhaps selenoprotein gene polymorphisms is envisaged
GMP is simply Current Good Manufacturing Practices and refers to compliance with current regulations
Pancreatitis There is a known, although rare, risk of acute pancreatitis with GLP-1RAs
doi: 10.2174/13816128113199990421